2022.02 Exhibited of MEDLAB 2023, Dubai, UAE
2022.02 Exhibited of WVC 2023, Las Vegas, Nevada
2023.03 Exhibited of EAU Congress 2023, Milan, Italy
2023.03 Exhibited of EXPOMED 2023, Istanbul, Turkey
2023.03 Exhibited of AD/PD 2023, Gothenburg, Sweden
2023.07 Exhibited of AACC 2023, Anaheim, USA
2022.01 Exhibited at MEDLAB 2022, Dubai, Arab Emirates
2022.05 Exhibited at Hospitala 2022, São Paulo, Brazil
2022.07 Exhibited at AACC 2022, Chicago, IL, US
2022.07 Exhibited at FIME 2022, Miami, FP, US
2022.07 Exhibited at AAIC 2022, San Diego, CA, US
2022.08 Exhibited at Medical Fair Asia 2022, Singapore, Singapore
2022.08 Exhibited at ESC 2022, Barcelona, Spain
2022.10 Exhibited at Medical japan 2022, Tokyo, Japan
2022.10 Exhibited at Africa Health 2022, Johannesburg, Africa
2022.11 Exhibited at Medica Germany 2022, Dusseldorf, Germany
2021.02 Acquired MFDS certificate approval of ABSOL VET
2021.03 Signed an agreement with NEODIN BIOVET
2021.03 Acquired manufacture license of Total T4
2021.04 Exhibited at Arab-Health 2021, Dubai, Arab Emirates (Online exhibition)
2021.05 Acquired manufacture license of cCortisol
2021.05 Acquired manufacture license of cCRP
2021.07 Acquired manufacture license of Free T4
2021.08 Acquired manufacture license of cTSH
2021.11 Exhibited at London Vet Show 2021, UK
2021.11 Exhibited at MEDICA 2021, Dusseldorf, Germany
2020. 02 Exhibited at CAMEX 2020, Korea
2020. 04 Changed company name to Aboslogy Co., Ltd
2020. 11 Exhibited at GVMA conference 2020, Korea
2019.02 Exhibited at MEDLAB 2019, Dubai, Arab Emirates
2019.03 Acquired GMP Certification
2019.04 Acquired
ISO 13485
2019.08 Exhibited at AACC 2019, Anaheim, CA, US
2019.11
Exhibited at MEDICA 2019, Düsseldorf, Germany
2018. 04 Exhibited at Analytics 2018, Munchen, Germany
2018. 04 Awarded a research grant from Ministry of Commerce Industry and Energy
2018. 08 Exhibited at AACC 2018, Chicago, US
2018. 11 Exhibited at MEDICA 2018. Dusseldorf, Germany
2018. 11 Acquired MFDS approval of ABSOL
2017. 03 Foundation of Intekbio Co., Ltd
2017. 11 Approved as a Venture company and acquired Enterprise institute license